Terazosin Hydrochloride
CAS 63074-08-8 13 FDA-DMF suppliersSmall Molecule
Overview
Terazosin Hydrochloride is an alpha-1 adrenergic blocker used to treat high blood pressure and benign prostatic hyperplasia. It works by relaxing the muscles in the prostate and part of the bladder, making it easier to urinate and lowering blood pressure.
API suppliers (13)
Suppliers of Terazosin Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- TAPI NL BV1 active DMF
- TAPI NL BV1 active DMF
- JUBILANT BIOSYS LTD1 active DMF
- TAPI NL BV1 active DMF
- JUBILANT BIOSYS LTD1 active DMF
- JUBILANT BIOSYS LTD1 active DMF
- SUMITOMO CHEMICAL CO LTDJapan
- PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
- BASF PHARMACHEMIKALIEN GMBH CO KG
- PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
- SECOND PHARMA CO LTDChina
- ARCHIMICA SRL
- STANDARD CHEM AND PHARM CO LTD
Therapeutic areas
HypertensionBenign Prostatic HyperplasiaCardiovascular System
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.